AmberLeeBeitelsheesPharmD, MPH

Amber Lee Beitelshees, MPH is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

PubMed

Correction: Evaluating the extent of reusability of CYP2C19 genotype data among patients genotyped for antiplatelet therapy selection.
Amber L Beitelshees, James M Stevenson, Nihal El Rouby, Chrisly Dillon, Philip E Empey
Genetics in Medicine. 2020-11-01
4 citations
Evaluating the extent of reusability of CYP2C19 genotype data among patients genotyped for antiplatelet therapy selection.
Amber L Beitelshees, James M Stevenson, Nihal El Rouby, Chrisly Dillon, Philip E Empey
Genetics in Medicine. 2020-11-01
7 citations
β 2 -Adrenergic Receptor Gene Affects the Heart Rate Response of β-Blockers: Evidence From 3 Clinical Studies.
Mohamed H. Shahin, Nihal El Rouby, Daniela J. Conrado, Daniel Gonzalez, Yan Gong
Journal of Clinical Pharmacology. 2019-11-01

Journal Articles

Prescribing Prevalence of Medications with Potential Genotype-Guided Dosing in Pediatric Patients
Amber L Beitelshees, Philip E Empey, Christopher M Horvat, Jeffrey R Bishop, JAMA Network Open

Uncoupling Protein Polymorphisms And Cardiometabolic Responses To Beta-BlockersNational Heart, Lung, And Blood Institute2008–2011
Pathway Pharmacogenetics And Angiotensin Receptor Blocker ResponsesNational Center For Research Resources2009
Uncoupling Protein Polymorphisms And Cardiometabolic Responses To Beta-BlockersNational Heart, Lung, And Blood Institute2008
Telmisartan PharmacogeneticsNational Center For Research Resources2007

Office
670 W Baltimore St, Room 4172
Baltimore, MD 21201
Phone+1 410-706-0118